GGrantIndex
← Leaderboards

Glen D Raffel

Beth Israel Deaconess Medical Center

$4,471,484
Attributed
$4,471,484
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $514.2K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$4,471,484 · 5

By mechanism

R01$2,056,613 · 1
U19$1,742,976 · 3
K08$671,895 · 1

Top collaborators

No co-investigators on record.

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Genes

Research focus

GenesHematopoieticCellsStem Cell TransplantHematopoietic Stem CellsStem CellsEngraftmentInfectionRegulationPhysiologicalReagentPropertyPathway InteractionsMediatingIn VitroMegakaryocytesHematopoiesisAffectAcute Megakaryocytic LeukemiasMolecularIn VivoKnock-OutAplastic AnemiaAllogenic

Grant awards (15)

Nongenotoxic conditioning for HIV cure transplantation approaches$186,854
U19 · FY2024 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$223,313
U19 · FY2023 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$399,503
U19 · FY2022 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$419,122
U19 · FY2021 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$514,184
U19 · FY2020 · AI · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$418,750
R01 · FY2017 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$418,750
R01 · FY2016 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$412,468
R01 · FY2015 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$410,375
R01 · FY2014 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$396,270
R01 · FY2013 · HL · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2009 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2008 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2007 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia.$134,379
K08 · FY2006 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2005 · CA